nigericin has been researched along with amentoflavone in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, G; Huang, T; Lan, C; Li, X; Peng, K; Qiu, C; Wang, Z; Yang, F; Yang, Y | 1 |
1 other study(ies) available for nigericin and amentoflavone
| Article | Year |
|---|---|
Amentoflavone mitigates doxorubicin-induced cardiotoxicity by suppressing cardiomyocyte pyroptosis and inflammation through inhibition of the STING/NLRP3 signalling pathway.
Topics: Animals; Apoptosis Regulatory Proteins; Body Weight; Breast Neoplasms; Cardiotoxicity; Doxorubicin; Female; Humans; Inflammation; Mice; Myocytes, Cardiac; Nigericin; NLR Family, Pyrin Domain-Containing 3 Protein; Pyroptosis; Rats; Rats, Sprague-Dawley | 2023 |